Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2992

Actual shortage: 230 (8%)
Anticipated shortage: 21 (1%)
Avoided shortage: 9 (0%)
Resolved: 2732 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-19 2021-03-15 134433
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-03-27 217481
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-01-12 206579
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949

Showing 1161 to 1180 of 2992

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2018-10-25 2018-10-25 65585
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-09-12 40841
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-10-25 40844
APO-ACETAMINOPHEN 325MG TABLET Discontinued 2018-10-11 2018-10-11 63845
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-02-21 70802
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-07-13 70805
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-08-08 70807
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO CHLORPROPAMIDE TAB 100MG 100MG TABLET Discontinued 2017-03-13 2017-03-13 1196
APO CHLORPROPAMIDE TAB 250MG 250 mg tablet Discontinued 2017-03-13 2018-02-05 1235
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-02-28 40835
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-05-07 40838

Showing 1 to 20 of 356